Fluoroquinolone Resistance in Neisseria gonorrhoeae: Fitness Cost or Benefit?

Predicting bacterial fitness cost associated with drug resistance

(2012) Beining Guo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Emerging Threat of Untreatable Gonococcal Infection

(2012) Gail A. Bolan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future

(2011) Magnus Unemo et al.   Annals of the New York Academy of Sciences

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure

(2011) Magnus Unemo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities

(2011) John Cherrington Carmen et al.   Frontiers in Microbiology

The Gonococcus fights back: is this time a knock out?

(2010) D. A. Lewis   SEXUALLY TRANSMITTED INFECTIONS

Multidrug-resistant Neisseria gonorrhoeae

(2009) J. Tapsall   CANADIAN MEDICAL ASSOCIATION JOURNAL

Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness

(2009) Linda L. Marcusson et al.   PLoS Pathogens